Moderna launches programs to support mRNA research
24 March, 2023Moderna has announced its inaugural Australian Fellowship Program to support scientists with an interest in advancing mRNA innovation, while also partnering with UQ on vaccines for public health threats.
Breakthrough bone cancer drug could increase survival rate
20 March, 2023UK researchers have developed a new drug that works against all of the main types of primary bone cancer, which is usually very difficult to treat.
Targeted drug delivery to treat brain tumours in children
15 March, 2023Novel technology allows for the enhanced delivery of anticancer drugs to the specific locations of brain tumours while sparing normal brain regions.
Hydrogel stem cell treatment repairs brain tissue in mice
06 March, 2023The hydrogel keeps stem cells alive for long enough to allow them to evolve into the cells required to create new tissue in the damaged part of the body.
'Forgotten' drug revisited as potential leukaemia treatment
23 February, 2023The drug, called PIK-75, was initially discovered over a decade ago but was dismissed in favour of newer ones.
$96m RNA facility coming to Macquarie University
22 February, 2023Myeloid Therapeutics will collaborate with the NSW Government to create a world-class RNA manufacturing and research facility at Macquarie University.
PrEP implant could enable long-term HIV protection
20 February, 2023Researchers have been collaborating on an injectable implant that can release HIV PrEP medications into the body over a long period of time, with promising results.
UQ vaccine to protect pigs from Japanese encephalitis virus
16 February, 2023UQ-developed chimera virus technology was used to make a 'hybrid' version of the virus, using a mosquito-only Australian virus that is harmless to humans.
Milestone as scientists regenerate diseased kidney
15 February, 2023Blocking a damaging and scar-regulating protein called interleukin-11 (IL-11) enables damaged kidney cells to regenerate, restoring impaired kidney function.
AcuraBio expands cGMP plasmid DNA CDMO services
14 February, 2023AcuraBio expects to produce more plasmid DNA for its customers around the world using Cytiva's latest bacterial plasmid two-step purification protocol.
2023 COVID-19 booster vaccine available for Aust adults
08 February, 2023Adults who have not had a COVID-19 booster or a confirmed case of COVID-19 in the past six months will soon be able to get another booster to give them additional protection.
TGA approves psychedelics for mental health treatment
06 February, 2023 by Lauren DavisFrom 1 July this year, the TGA will permit the prescribing of MDMA for post-traumatic stress disorder and psilocybin for treatment-resistant depression.
Artificial DNA kills cancer cells
26 January, 2023Researchers developed a chemically synthesised, hairpin-shaped DNA strand that can activate a natural immune response to target and kill specific cancerous cells.
Light therapy eliminates antibiotic-resistant superbugs
23 January, 2023The photodynamic technology harnesses the energy of light to generate highly reactive oxygen molecules that eradicate microbial cells and kill deadly bacteria.
Queensland invests in global mRNA vaccine hub
08 December, 2022Sanofi has partnered with the Queensland Government, The University of Queensland and Griffith University to inject $280 million into a next-generation mRNA vaccine research hub.
